VREOF Research | Milton Maxwell

VREOF

Vireo Growth Inc.

0.6290

+0.0490+8.45%

Dec 16, 4:00:00 PM EST

Upcoming Earnings

Report date

-/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap

672.55M

P/E (TTM)

Basic EPS (TTM)

-0.16

Dividend Yield

Recent Filings

8-K

12/10/25Dec 10, 2025

8-K

11/12/25Nov 12, 2025

10-Q

11/12/25Nov 12, 2025

8-K

11/3/25Nov 3, 2025

8-K

Vireo acquires Schwazze notes, eyes assets

10/14/25Oct 14, 2025

Vireo Growth Inc. closed its acquisition of 86% of Schwazze's $91 million senior secured notes for $62 million in shares on October 10, 2025, gaining majority control and directing a credit bid for Schwazze's key assets via a restructuring support agreement. This positions Vireo to form NewCo for the asset purchase, backed by $62 million financing to refinance debts and fund operations in Colorado and New Mexico's 63 dispensaries. Yet risks loom from competing bids and regulatory hurdles. Deal hinges on milestones through November.

About

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

CEO

Dr. Kyle E. Kingsley M.D.

IPO

3/22/2019

Website

https://www.vireogrowth.com

Employees

419

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic